Researcher
Wei Leong Chew is a Principal Scientist II and Associate Director at the Genome Institute of Singapore (GIS). He is known for his pioneering work with CRISPR-Cas gene editors and for his insights into the safety and efficacy profiles of nucleic acid therapeutics. His research interests are focused on gene editing, gene therapy, synthetic biology and nucleic acid technologies.
Related Articles
Gene editing cuts to the chase
6 Feb 2024A programmable gene editing tool targets and eliminates a rapidly mutating RNA virus responsible for
Correcting glitches in human genes
31 Aug 2021Precise and efficient C:G to G:C gene-editing enzymes could pave the way for new treatments